<DOC>
	<DOCNO>NCT01102452</DOCNO>
	<brief_summary>To evaluate result PPB-R-203-02 base noodle commercially available wet noodle blood glucose control 24 patient diabetes 2 day .</brief_summary>
	<brief_title>A Study Evaluate Blood Glucose Regulation Safety PPB-R-203-02 Based Noodle Versus Commercially Available Wet Noodle Patients With Diabetes</brief_title>
	<detailed_description>The MiniMed Medtronic CGMS ( continuous glucose monitor system ) , first model approve FDA , use subcutaneous glucose monitoring . The CGMS continually measure glucose concentration interstitial fluid every 10 second store average glucose value 5 minute period , total 288 measurement day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>1 . Diabetes mellitus patient . 2 . Aged 20 65 year old . 3 . Informed consent form sign . 1 . A recent history drug alcohol abuse . 2 . Sensitivity analogous product . 3 . Serious cardiovascular disorder . 4 . Participation another clinical investigation study . 5 . Ongoing influenza , autoimmune disease metabolic disease . 6 . Pregnant lactating woman . 7 . Individuals judge investigator coinvestigator undesirable subject .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>